| Subject: | RECALL of Fluorouracil Injection, USP, 50 mg/mL, 500mg/10 mL Single Dose Vial |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Thu, 29 Sep 2005 - 10:00 am |
| American Pharmaceutical Partners, Inc., (APP) has recalled all lots of Fluorouracil Injection, USP, 50 mg/mL, (500mg/10 mL Single Dose Vial), because of the potential for invisible glass particles to be present in vials of Fluorouracil Injection, USP, 50 mg/mL, (500mg/10 mL Single Dose Vial). These particles are composed of the glass constituents, silica and aluminum.
Only Product Code 101710 is susceptible to this type of glass breakdown. APP's other Fluorouracil product codes are... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
Related MCN Products:
|
|
StayAlert!® Virtual Compliance Administrator™ keeps clients informed by email of any changes to Federal regulations, including Joint Commission (TJC, formerly JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG, and many more, and also provides downloadable tools to ensure compliance. StayAlert! is a premium product sold as an annual site-license subscription. With the site license, the client can sign up an unlimited number of users for the email alerts and access to the StayAlert! online regulatory library. The strength of StayAlert! rests in its ability to allow healthcare organizations to streamline their businesses using the Internet as a foundation architecture. StayAlert! provides cost containment and reduction through elimination of unnecessary overhead, and work caused by errors or poor access to information. |
|
